Lazard Asset Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8K Sell
2025
Q1
$358K Sell
2024
Q4
$959K Buy
2024
Q3
$630K Buy
2024
Q2
$43K Buy
2024
Q1
$2K Sell
2023
Q4
$40K Buy
2023
Q3
Sell
2023
Q2
$36K Buy